Lower plasma sodium is associated with a microinflammatory state among patients with advanced chronic kidney disease

Nephron - Clinical Practice

Volumn 128, Issue , 2014, Pages 312-318

  Ortega, Olimpia ^a   Cobo, Gabriela ^a   Rodríguez, Isabel ^a   Camacho, Rosa ^a   Gallar, Paloma ^a   Mon, Carmen ^a   Herrero, Juan Carlos ^a   Ortiz, Milagros ^a   Oliet, Aniana ^a   Di Gioia, Cristina ^a   Vigil, Ana ^a  

^a HOSPITAL SEVERO OCHOA   (Spain)

Author keywords

Chronic kidney disease; Inflammation; Sodium

Indexed keywords

C REACTIVE PROTEIN; CREATININE; ERYTHROPOIETIN; HEMOGLOBIN; SERUM ALBUMIN; SODIUM; BIOLOGICAL MARKER;

AGED; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EXTRACELLULAR FLUID; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HUMAN; IMPEDANCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROINFLAMMATORY STATE; MOLECULAR EVOLUTION; OUTCOME ASSESSMENT; PLASMA VOLUME; PREVALENCE; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; DIAGNOSIS; HEART LEFT VENTRICLE FUNCTION; MORTALITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR;

AGED; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; ECHOCARDIOGRAPHY; ELECTRIC IMPEDANCE; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SODIUM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84922925521     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000368116     Document Type: Article

References (25)

1. Match WE, Wilcox CS: Disorders of body fluids, sodium and potassium in chronic renal failure. Am J Med 1982; 72:447-457.
2. Tuso PJ, Nissenson AR, Danovitch GM: Electrolyte disorders in chronic renal failure; in Narins RG (ed): Maxwell & Kleeman's Clinical Disorders of Fluid and Electrolyte Metabolism. New York, McGraw-Hill, 1994, pp 1195-1211.
3. Kovesdy CP: Significance of hypo-And hyper-natremia in chronic kidney disease. Nephrol Dial Transplant 2012; 27:891-898.
4. Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE: Impact of hospital-Associated hypo-natremia on selected outcomes. Arch Intern Med 2010; 170:294-302.
5. Waikar SS, Mount DB, Curhan GC: Mortality after hospitalization with mild, moderate and severe hyponatremia. Am J Med 2009; 122: 857-865.
6. Mohammed AA, van Kimmenade RR, Richards M, Bayes-Genis A, Pinto Y, Moore SA, Januzzi JL Jr: Hyponatremia, natriuretic pep-tides, and outcomes in acutely decompensat-ed heart failure. Results from the International Collaborative of NT-proBNP Study. Circ Heart Fail 2010; 3:354-361.
7. Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamps AS, Piña IL, Fonarow GC, DeMar-co T, Pauly DF, Rogers J, DiSalvo TG, Butter J, Hare JM, Francis GS, Stough WG, O'Connor CM: Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med 2007; 167:1998-2005.
8. Waikar SS, Curhan GC, Brunelli SM: Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med 2011; 124:77-84.
9. Hecking M, Karaboyas A, Saran RS, Sen A, Horl WH, Pisoni RL, Robinson BM, Sunder-Plassmann G, Port FK: Predialysis serum sodium level, dialysate sodium and mortality in maintenance hemodialysis patients: the dialysis outcomes and practice study (DOPPS). Am J Kidney Dis 2012; 59:238-248.
10. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, Kalantar-Zadeh K: Hyponatremia, hypernatremia and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 2012; 125:677-684.
11. Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode CH, Malecka-Masalska T, Marcelli D: The mortality risk of overhydra-tion in hemodialysis patients. Nephrol Dial Transplant 2009; 24:1574-1579.
12. Beukhof CM, Hoorn EJ, Lindemans J, Zietse R: Novel risk factors for hospital-Acquired hy-ponatremia: a matched case-control study. Clin Endocrinol (Oxf) 2007; 66:367-372.
13. Swart RM, Hoorn EJ, Betjes MG, Zietse R: Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol 2011; 118:45-51.
14. Yee-Moon Wang A, Lu Y, Cheung S, Hiu-Shuen Chan I, Wai-Kei Lam C: Plasma sodium and subclinical left atrial enlargement in chronic kidney disease. Nephrol Dial Transplant 2013; 28:2319-2328.
15. Almond CS, Shin AY, Fortescue EB, Mannix RC, Wypij D, Binstadt BA, Duncan CN, Olson DP, Salerno AE, Newburger JW, Greenes DS: Hyponatremia among runners in the Boston Marathon. N Engl J Med 2005; 352:1550-1556.
16. Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R: Incidence and risk factors for hyponatre-mia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol 1999; 47:211-217.
17. Sanches FM, Avesani CM, Kamimura MA, Lemos MM, Axelsson J, Vasselai P, Draibe SA, Cuppari L: Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 2008; 52:66-67.
18. Ramos LF, Shintani A, Ikizler TA, Himmel-farb J: Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol 2008; 19:593-599.
19. Ramkumar N, Cheung AK, Pappas LM, Roberts WL, Beddhu S: Association of obesity with inflammation in chronic kidney disease: a cross-sectional study. J Ren Nutr 2004; 14: 201-207.
20. Cordeiro AC, Qureshi AR, Stenvinkel P, Heimburger O, Axelsson J, Barany P, Lind-holm B, Carrero JJ: Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing hemodialysis. Nephrol Dial Transplant 2010; 25:562-568.
21. Axelsson J, Rashid QA, Suliman ME, Honda H, Pecoits-Filho R, Heimburger O, Lindholm B, Cederholm T, Stenvinkel P: Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004; 80: 1222-1229.
22. Carvalho LK, Silva MIB, Vale BS, Bregman R, Martucci RB, Carrero JJ, Avesani CM: Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients stages 3 and 4: a longitudinal study. Nephrol Dial Transplant 2012; 27:1423-1428.
23. Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD: Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 2003; 42:761-773.
24. Shantouf R, Budoff M, Ahmadi N, Tiano J, Flores F, Kalantar-Zadeh K: Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients. Am J Nephrol 2008; 28: 275-279.
25. Wanner C, Metzger T: C-reactive protein a marker for all-cause and cardiovascular mortality in hemodialysis patients. Nephrol Dial Transplant 2002; 17(suppl 8):29-32.